Digital-Pathology-Today

Lisa-Jean Clifford is Chief Operating Officer and Chief Strategy Officer at Gestalt Diagnostics. We discuss parallels between pathology and radiology in their digital journeys, the steps involved in going digital, how to keep the various stakeholders engaged and enthusiastic. We posed the question: “ Have we finally made the business case for digital pathology?” Lisa-Jean tells us about the user e...

This episode with Dr. Ken Bloom of Nucleai, we examine the beginnings of telepathology, which led to what we now know as digital pathology in the 1980s. We trace the journey to now, focusing on seminal events in the industry, such as computational pathology, computer-assisted image analysis, the development of CPT codes, the importance of the TCPC split, particularly in the reference lab setting,...

We know that there are certain tasks pathologists are often not very good at or may prefer not to do, such as counting cells or estimating tumor volume. Why not free them up from these tasks and allow them to focus on other areas where they can add more value? As technology accelerates and drug discovery quickens, there are more and more studies being conducted and fewer pathologists available to...

What does the CRO of the future look like? In diagnostics we seem to be inundated with more platforms, more analytes more “-omics” and more pathways. How do we make sense of it all? What is the future of multi-omic analysis and what role will digital pathology play in understanding biological pathways, clinical trials, multi-omics and the development of companion diagnostics? Christopher Ung, Chie...

What is the state of the industry in 2023 in terms of driving towards unified file formats? Is middleware or software to bridge between various components and file formats still necessary and if so for how long? Why do we even have different file formats? Is it a feature or a bug? Rudy Hovelinck is the CEO of Pathomation, where he directs the company efforts to deliver high quality universal digit...

“We shall not cease from exploration and the end of all our exploring will be to arrive where we started and know the place for the first time” - TS Eliot. Is it possible to predict molecular biomarkers from H&E sections through deep learning and computer vision? After all the Hematoxylin and Eosin section was one of our first tools in our arsenal. Molecular diagnostics came center stage in the 19...

Amidst this digital transformation in pathology, it’s not only the review of histologic sections that is going digital and moving online, but practically everything else is too. What does this mean for the future of publishing and pathology education with the advent of online content and delivery mechanisms? Our guest is Jason Hornick, MD, PhD, Director of Surgical Pathology and Immunohistochemist...

One of the biggest pieces of news we've gotten in 2022 is the announcement of new CPT codes from the American Medical Association specifically for digital pathology. What are CPT codes? Why should we care? How will these new codes help us to elevate the practice of anatomic pathology and allow us to more concretely articulate a value proposition for digital pathology? Our guest is Nathan Buchbinde...

Conquering cancer through Artificial Intelligence is the goal of our guest this week on Digital Pathology today. We're talking with Brandon Suh, MD, CEO of Lunit, a South Korean company creating applications utilizing Artificial Intelligence in both digital pathology as well as radiology. Lunit stands for “learning unit,” which is fundamental to the company's philosophy which embodies the belief t...

As we kick off this third season of digital pathology today our guest is Dr. Kevin Sandeman, from the Region Skane in Sweden, who is going to be taking us through their digital transformation. The Region Skane covers a population of over 1.4 million people, involves four health care systems including two academic and two community centers. The caseload is over 110,000 cases per year - generating o...

The digital transformation in pathology is well underway but what kind of opportunities does this present to us? We've heard all the buzz words such as machine learning artificial intelligence and heard all the hype about enhanced workflows and making pathologists’ lives easier. What is the future practice of pathology going to look like? Our guest is Beatrice Knudsen, MD, PhD, Medical Director of...

They're coming - AI and machine learning algorithms in digital pathology. How do we go about assessing the robustness and suitability of these new tool for use in actual clinical practice? Our guests are Dr. Angelique Levi, Associate Professor of Pathology and Vice Chair and Director of Pathology Outreach Services and Dr. Sudhir Perincheri, Assistant Professor of Pathology and Director of Digital...

Too many systems or components in a pathology workflow adds complexity and cost. How can we create an elegant end to end solution to enhance workflows, while decreasing both complexity and costs? Our guest is John Wirthlin, CEO of Lumea, a company reimagining pathology - beginning and ending with the patient. We discuss the end-to-end solution in digital pathology. One of the promises of digital p...

Amidst this digital transformation in pathology the talk seems to be largely centered around whole slide imaging of H&E-stained tissue sections. But what about cytology? Why don't we hear much talk about digital cytology, and what are some of the unique challenges in cytology in terms of going digital. Our guest is Michael Quick, Vice President of Research and Development and Innovation at Hologic...

What is going to surprise us in digital pathology in big ways and in small ways? How can seemingly small changes make a big impact in what we do as pathologists and in the lives of patients? How are we going to make use of the large datasets that we will inevitably be generating through the widescale adoption of digital pathology? Our guest is Louis Culot, General Manager for Genomics and Oncology...

It's easy to get caught up in the hype surrounding digital pathology. But what is actually involved and going digital? What are the steps involved? We know about scanners and viewing images, of course. But what other pieces of software might be necessary or helpful? Coleman Stavish is co-founder and CTO at Proscia, a leading provider of digital and computational pathology solutions. At Proscia, Co...

NVIDIA is involved in computer graphics, artificial intelligence, computing and processors across variety of industries including gaming, entertainment, finance, and health care. What are the commonalties of all these industries and what lesson from other fields can we apply to healthcare? Our guest is Craig Rhodes EMEA Industry Lead - AI for Healthcare and Life Sciences at NVIDIA. There is the pe...

Our guests are Dr. Garth Bryson Consultant Pathologist and Clinical Director for Laboratory Medicine at the NHS Greater Glasgow and Clyde and Dr. David Harrison, Professor of Pathology from the University of Saint Andrews, and both from ICAIRD - the Industrial Center for Artificial Intelligence Research and Digital Diagnostics a program matching AI solutions and research with health and social car...

Our guest is one of the giants in the field of digital pathology and image analysis. And if he has seen further than others, he will tell you, it is because he was able to stand on the shoulders of giants as well. His unique multidisciplinary approach has allowed him to breakdown silos and see across the often-artificial barriers and distinctions imposed by academic disciplines and patient treatme...

What have we been waiting for? What's taking so long? Much of the technology surrounding digital pathology has been with us for over 20 years. After fits and starts and initial excitement we've been left with disappointment in the past ten years. But now, it seems like the tide is turning and the digital transformation is here. Our guest is Richard Lash, MD, Chief Medical Officer from Lumea, a com...

We've all seen it in science fiction movies and maybe somewhat in consumer tech culture with things like Google glasses, or Pokémon GO. Augmented reality – an enhanced version of the physical world through the use of digital visual elements - does it have a role in digital pathology? Gabe Siegel is the CEO and co-founder of Augmentiqs, a company that develops augmented reality and digital patholog...

In this digital transformation of pathology, much of the focus is, of course, on the imaging of histologic sections or glass slides, which were once viewed under the microscope. It's often easy to forget that the examination of the specimen begins much earlier in the process - in the gross room or even in the operating room. Our guest is Vikram Butani, CEO and founder of Kubtec, whose passion is d...

The big trend in oncology over the past few years has been immunotherapy. this trend is converging with the digital transformation we are undergoing in pathology we seem to be at the crossroads of immune-oncology, digital pathology, image analysis, artificial intelligence, and the increasing ability to Multiplex. Our guest is Keith Wharton Jr., MD, PhD from Ultivue, a company looking to reveal act...

The Armed Forces Institute of Pathology (AFIP) was in existence from 1862 to 2011. Many of us in pathology know it as the publisher of the “tumor fascicles” or the Atlas of Tumor Pathology series, originating in 1947, as well as a center of consultation and tissue repository unparalleled in the world. The AFIP was reborn as the Joint Pathology Center (JPC), whose mission is to deliver cost-effecti...

We hear that multiple file formats or perhaps, more importantly, lack of a uniform file format seems to be a big issue in digital pathology. Why is this? What do we even mean by a file format? And will we be able to overcome this barrier on the road to full scale adoption of digital pathology? Yves Sucaet, a PhD in Bioinformatics, has a research background in systems and network biology. In 2012,...